Glomerular filtration rate by different measures and albuminuria are associated with risk of frailty: the Rugao Longitudinal Ageing Study

Hui Zhang,Meng Hao,Yi Li,Xiaoyan Jiang,Mengjing Wang,Jing Chen,Xiaofeng Wang,Xuehui Sun
DOI: https://doi.org/10.1007/s40520-022-02245-2
2022-01-01
Aging Clinical and Experimental Research
Abstract:Background and aim A decreased estimated glomerular filtration rate (eGFR) is associated with frailty, but the association between kidney function and frailty using multidimensional assessments has not been entirely examined. We aimed to investigate whether albuminuria and the eGFR using different biomarkers were associated with frailty. Methods A total of 1830 older adults were included. Kidney function was assessed by the eGFR (based on combined creatinine-cystatin C [eGFR cr-cys ]) and β 2 -microglobulin [eGFR B2M ]) and urine albumin-creatinine ratio (UACR). Frailty was measured by the Fried phenotype (FP) and frailty index (FI). Logistic regression models were used to investigate cross-sectional and longitudinal associations of baseline kidney measures with prevalent and incident frailty. Results At baseline, kidney function was associated with prevalent frailty. During the 2-year follow-up, a decreased eGFR (per 10 units) was associated with an increased risk of incident frailty using the FP (eGFR cr-cys : OR 1.18, 95% CI 1.03–1.35; eGFR B2M : OR 1.14, 95% CI 1.02–1.29, respectively) and FI (eGFR B2M : OR 1.18, 95% CI 1.04–1.65). An increased logUACR was associated with a higher risk of incident frailty using the FP (OR 1.18, 95% CI 1.03–1.35). Additionally, individuals with chronic kidney disease (CKD) had a higher risk of incident frailty using the FP (eGFR cr-cys : OR 2.13, 95% CI 1.28–3.47; eGFR B2M : OR 1.58, 95% CI 1.10–2.29, respectively) and FI (eGFR cr-cys : OR 1.97, 95% CI 1.15–3.32; eGFR B2M : OR 1.51, 95% CI 1.03–2.24, respectively). Conclusion Kidney function decline and CKD were associated with an increased risk of prevalent and incident frailty in older adults. Physicians should pay more attention to monitoring frailty status in older adults with CKD, even in those with kidney function decline.
What problem does this paper attempt to address?